T 0694/01 (Test device/UNILEVER) of 04.07.2002
- European Case Law Identifier
- ECLI:EP:BA:2002:T069401.20020704
- Date of decision
- 4 July 2002
- Case number
- T 0694/01
- Petition for review of
- -
- Application number
- 88303744.2
- IPC class
- G01N 33/543
- Language of proceedings
- English
- Distribution
- Published in the EPO's Official Journal (A)
- Download
- Decision in English
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Immunoassays and devices therefor
- Applicant name
- UNILEVER N. V.
- Opponent name
- (01) VEDALAB
(02) Carter-Wallace Inc.
(03) GENZYME CORPORATION
(04) Andrea von Preen
(05) Int. Mycoplasma
(06) Technical Chemicals & Products Inc.
(08) ORAMON Arzneimittel GmbH
(09) Pharma Peter
(10) ulti med Products (Deutschland)
(11) Cardimac Gesellschaft für Diagnostische Schnellteste mbH - Board
- 3.3.04
- Headnote
An intervention is dependent on the extent to which opposition/appeal proceedings are still pending.
Where a board has decided that a patent is to be maintained on the basis of a given set of claims and a description to be adapted thereto, a party intervening during subsequent appeal proceedings confined to the issue of the adaptation of the description cannot challenge the res judicata effect of the previous board of appeal decision regardless of whether a new ground for opposition is introduced.
- Relevant legal provisions
- European Patent Convention Art 105 1973
- Keywords
- Intervention during pending appeal proceedings - admissibility (yes)
New ground for opposition - void -
Scope of appeal limited to adaptation of description
Claims - res judicata - Catchword
- -
ORDER
For these reasons it is decided that:
1. The requests for referral of questions of law to the Enlarged Board of Appeal are refused.
2. The appeals and the intervention are dismissed.